Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.23.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Research and development $ 1,089,342 $ 915,363 $ 4,183,038 $ 1,843,397
General and administrative 1,774,699 964,281 5,106,172 2,662,293
Total operating expenses 2,864,041 1,879,644 9,289,210 4,505,690
Loss from operations (2,864,041) (1,879,644) (9,289,210) (4,505,690)
Other income, net 66,070 3,153 52,452 2,813
Net loss $ (2,797,971) $ (1,876,491) $ (9,236,758) $ (4,502,877)
Weighted average common shares outstanding, basic and diluted 25,633,217 23,344,567 24,888,916 23,344,567
Net loss per share, basic and diluted $ (0.11) $ (0.08) $ (0.37) $ (0.19)